10.6002/ect.mesot2023.o16
-
Published:2024-01
Issue:Suppl 1
Volume:22
Page:
-
ISSN:1304-0855
-
Container-title:Experimental and Clinical Transplantation
-
language:
-
Short-container-title:Exp Clin Transplant
Publisher
Baskent University
Reference20 articles.
1. 1. Vulpio C, Bossola M. Parathyroid nodular hyperplasia and responsiveness to drug therapy in renal secondary hyperparathyroidism: an open question. Ther Apher Dial. 2018;22(1):11-21. doi:10.1111/1744-9987.12604
2. 2. Fukagawa M, Nakanishi S. Role of parathyroid intervention in the management of secondary hyperparathyroidism. Nephrol Dial Transplant. 2003;18 Suppl 3:iii23-26. doi:10.1093/ndt/gfg1006
3. 3. Yamamoto M, Ogata H, Mizobuchi M, et al. Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism. Clin Exp Nephrol. 2012;16(2):292-299. doi:10.1007/s10157-011-0547-5
4. 4. Tominaga Y, Inaguma D, Matsuoka S, et al. Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism? Ther Apher Dial. 2006;10(2):198-204. doi:10.1111/j.1744-9987.2006.00364.x
5. 5. Fuster D, Torregrosa JV, Domenech B, et al. Dual-phase 99mTc-MIBI scintigraphy to assess calcimimetic effect in patients on haemodialysis with secondary hyperparathyroidism. Nucl Med Commun. 2009;30(11):890-894. doi:10.1097/MNM.0b013e3283305df6